Chen Fu
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
- Inorganic Chemistry top 5%
- Asymmetric Hydrogenation and Catalysis
Papers in
- Oncology 18
- Metal complexes synthesis and properties 9
- Viral-associated cancers and disorders 7
-
- Asymmetric Hydrogenation and Catalysis 6
- Co-authors
- Ailing Fu (15 shared papers)Eric Meggers (8 shared papers)Klaus Harms (8 shared papers)Haohua Huo (2 shared papers)Ming Zhao (1 shared paper)George Klein (5 shared papers)Qi Chen (1 shared paper)Li–Fu Hu (3 shared papers)
In The Last Decade
Chen Fu
76 papers receiving 2.0k citations
Chen Fu's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 466
- Inorganic Chemistry 210
- Organic Chemistry 417
- Biomaterials 158
- Pathology and Forensic Medicine 191
Countries citing papers authored by Chen Fu
This map shows the geographic impact of Chen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Fu more than expected).
Fields of papers citing papers by Chen Fu
This network shows the impact of papers produced by Chen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Fu. The network helps show where Chen Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 178 | |
| 2 | Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. | 1993 | 177 |
| 3 | 2014 | 166 | |
| 4 | 2019 | 80 | |
| 5 | 1998 | 80 | |
| 6 | 2020 | 79 | |
| 7 | 2019 | 75 | |
| 8 | 2021 | 69 | |
| 9 | 2017 | 61 | |
| 10 | The future of pharmaceuticals: Artificial intelligence in drug discovery and development Hit paper breakdown → | 2025 | 61 |
| 11 | 2020 | 56 | |
| 12 | 2018 | 56 | |
| 13 | 2014 | 55 | |
| 14 | 1996 | 47 | |
| 15 | 2021 | 46 | |
| 16 | 2014 | 45 | |
| 17 | 2017 | 42 | |
| 18 | 2018 | 40 | |
| 19 | 2017 | 39 | |
| 20 | 2018 | 37 |
About Chen Fu
Chen Fu is a scholar working on Oncology, Inorganic Chemistry, Organic Chemistry, Molecular Biology and Infectious Diseases, having authored 77 papers that have together received 2.1k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (9 papers), Viral-associated cancers and disorders (7 papers), Asymmetric Hydrogenation and Catalysis (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanocluster Synthesis and Applications (5 papers), Parvovirus B19 Infection Studies (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Organometallic Complex Synthesis and Catalysis (4 papers). The work is most often cited by research in Oncology (466 citations), Inorganic Chemistry (210 citations), Organic Chemistry (417 citations), Biomaterials (158 citations) and Pathology and Forensic Medicine (191 citations). Chen Fu has collaborated with scholars based in China, Sweden and Germany. Frequent co-authors include Ailing Fu, Eric Meggers, Klaus Harms, Haohua Huo, Ming Zhao, George Klein, Qi Chen, Li–Fu Hu, Gösta Winberg and Ingemar Ernberg. Their work appears in journals such as Materials Science and Engineering C, Chemical Communications, International Journal of Cancer, Inorganic Chemistry and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.